|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
108.15(B) |
Last
Volume: |
4,786,595 |
Avg
Vol: |
8,429,684 |
52
Week Range: |
$48.64 - $75.67 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
250,541 |
430,874 |
929,865 |
2,041,378 |
Total Sell Value |
$18,359,902 |
$29,055,549 |
$55,374,067 |
$104,875,147 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
14 |
25 |
42 |
77 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,970 |
92,858 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2023-02-16 |
4 |
D |
$46.48 |
$27,005 |
D/D |
(581) |
36,350 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,272 |
36,931 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-02-16 |
4 |
D |
$46.48 |
$83,943 |
D/D |
(1,806) |
214,318 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,960 |
216,124 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2023-02-16 |
4 |
D |
$46.48 |
$60,889 |
D/D |
(1,310) |
62,367 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,262 |
63,677 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2023-02-16 |
4 |
D |
$46.48 |
$26,401 |
D/D |
(568) |
39,872 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,838 |
40,440 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-02-16 |
4 |
D |
$46.48 |
$335,307 |
D/D |
(7,214) |
1,822,201 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,264 |
1,829,415 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-02-16 |
4 |
D |
$46.48 |
$42,297 |
D/D |
(910) |
90,749 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,050 |
91,659 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2023-02-16 |
4 |
D |
$46.48 |
$58,100 |
D/D |
(1,250) |
279,309 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,243 |
280,559 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2023-02-16 |
4 |
D |
$46.48 |
$21,195 |
D/D |
(456) |
33,535 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
990 |
33,991 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-02-16 |
4 |
D |
$46.48 |
$52,476 |
D/D |
(1,129) |
25,835 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,545 |
26,964 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-02-15 |
4/A |
D |
$47.29 |
$107,727 |
D/D |
(2,278) |
212,164 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-02-15 |
4 |
D |
$47.29 |
$117,658 |
D/D |
(2,488) |
211,954 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,615 |
214,442 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2023-02-15 |
4 |
D |
$47.29 |
$50,553 |
D/D |
(1,069) |
61,415 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,846 |
62,484 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-02-15 |
4 |
D |
$47.29 |
$34,853 |
D/D |
(737) |
89,609 |
|
- |
|
2518 Records found
|
|
Page 12 of 101 |
|
|